Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 14/20 | 0.58 |
| ▸ | FNTB | P49356 | 14/20 | 0.58 |
| ▸ | CYP11B1 | P15538 | 3/20 | 0.46 |
| ▸ | CYP11B2 | P19099 | 3/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | DRD2 | P14416 | 1/20 | 0.39 |
| ▸ | HTR7 | P34969 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7660901 | 0.89 | FNTA (0.56) | FNTAFNTBCYP11B1CYP11B2 | |
| SCHEMBL7659227 | 0.86 | FNTA (0.57) | FNTAFNTBCYP11B1CYP11B2 | |
| SCHEMBL7650637 | 0.79 | FNTA (0.49) | FNTAFNTBCYP11B1CYP11B2 | |
| SCHEMBL7655285 | 0.79 | FNTA (0.76) | FNTAFNTBCYP11B1CYP11B2 | |
| SCHEMBL7654962 | 0.76 | FNTA (0.59) | FNTAFNTBCYP11B1CYP11B2 | |
| SCHEMBL7657532 | 0.74 | FNTA (0.64) | FNTAFNTBCYP11B1CYP11B2 | |
| SCHEMBL7654971 | 0.74 | FNTA (0.68) | FNTAFNTBCYP11B1CYP11B2 | |
| SCHEMBL7659414 | 0.74 | FNTA (0.63) | FNTAFNTBCYP11B1CYP11B2 | |
| SCHEMBL7655758 | 0.73 | FNTA (0.61) | FNTAFNTBCYP11B1CYP11B2 | |
| SCHEMBL7661055 | 0.72 | FNTA (0.60) | FNTAFNTBCYP11B1CYP11B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6384061-B1 | HYDANTOIN COMPOUNDS REPRESENTED BY FORMULA (I) WHICH SHOWS AN INHIBITORY ACTIVITY AGAINST FARNESYL TRANSFERASE, AND THUS CAN BE USED AS AN ANTI-CANCER AGENT, OR PHARMACEUTICALLY ACCEPTABLE SALTS | LG CHEMICAL LTD. (KR) | 2002-05-07 | — | — | US | claimed |
| US-6384061-B1 | HYDANTOIN COMPOUNDS REPRESENTED BY FORMULA (I) WHICH SHOWS AN INHIBITORY ACTIVITY AGAINST FARNESYL TRANSFERASE, AND THUS CAN BE USED AS AN ANTI-CANCER AGENT, OR PHARMACEUTICALLY ACCEPTABLE SALTS | LG CHEMICAL LTD. (KR) | 2002-05-07 | — | — | US | disclosed |